AlbertBourlaOvěřený účet

@AlbertBourla

Chairman and CEO of . Father. 🇬🇷🇺🇸 Working every day for breakthroughs that change patients’ lives.

New York, NY
pfizer.com
Připojil se červenec 2019
76 fotek nebo videí Fotky a videa

tweety/tweetů

Zablokovali jste uživatele @AlbertBourla.

Opravdu chcete tyto tweety zobrazit? Zobrazením tweetů nedojde k odblokování uživatele @AlbertBourla.

  1. 30. 8.

    We are pleased to announce positive top-line results today from our Phase 3 JADE DARE trial in abrocitinib and are committed to developing a potential new treatment option for people living with moderate to severe :

    11 replies 11 retweetů 104lajků
    Vrátit
  2. 27. 8.

    Great news that doses of our vaccine have arrived in Vietnam. We look forward to continuing our work with the Administration to help solve this ongoing health crisis and reach our goal of providing vaccines to people in ALL countries.

    763,000+ vaccine doses, from the 1M additional U.S.-donated doses announced by Kamala Harris, have arrived in Vietnam! The remaining vaccines will arrive in Vietnam tomorrow, August 27. Together we will defeat -19. 🇺🇸🤝🇻🇳 Photo credit: © AP Images
    31 replies 9 retweetů 100lajků
    Vrátit
  3. 26. 8.

    As we look to the next era of innovation and a future filled with opportunities, I am very pleased to announce that Aamir Malik will join as Executive Vice President, Chief Business Innovation Officer:

    48 replies 15 retweetů 115lajků
    Vrátit
  4. 26. 8.

    We continue to expand our supply chain network, collaborating with Brazilian biopharma company to manufacture and distribute our vaccine across Latin America:

    9 replies 11 retweetů 87lajků
    Vrátit
  5. 25. 8.

    Vaccines have been and will remain critical to helping protect lives against , and if approved, we believe doses could accelerate our path out of the pandemic.

    18 replies 5 retweetů 75lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit
  6. 25. 8.

    Based on Phase 3 data, we've initiated submission of a supplemental Biologics License Application to for approval of a third (or ) dose of our vaccine:

    24 replies 58 retweetů 249lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit
  7. 23. 8.

    It is our hope that this news will instill even further public confidence in our vaccine and the science that made it possible.

    31 replies 28 retweetů 263lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit
  8. 23. 8.

    Today, with our partners at , we are celebrating 's approval of our for individuals 16 years of age and older:

    29 replies 99 retweetů 456lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit
  9. 23. 8.

    Every day, I wake up proud of our team at . Proud of the work we do. Proud of the difference we are making. And I am especially proud today.

    157 replies 204 retweetů 2 620lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit
  10. 23. 8.

    Uniting cutting-edge science and our deep experience in hematological cancers, we are proud to announce a new agreement under which Pfizer will acquire Trillium Therapeutics:

    17 retweetů 120lajků
    Vrátit
  11. 17. 8.

    “It takes me back to when I was a scared six-year-old in … Everyone deserves a chance. A fair shot.” A deeply heartfelt and powerful message from our Chief Human Resources Officer Payal Sahni.

    9 replies 13 retweetů 84lajků
    Vrátit
  12. 16. 8.

    The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by FDA but has been authorized for emergency use to prevent COVID-19 in ages 12+. See Fact Sheet:
    Zobrazit toto vlákno
    9 replies 17 retweetů 84lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit
  13. 16. 8.

    Our Phase 3 third dose results are expected shortly and will be submitted to the FDA. We continue to follow the science and we are prepared to manufacture booster doses, if authorized or approved. (2/2)

    26 replies 58 retweetů 295lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit
  14. 16. 8.

    An important update today. We have submitted initial data to that suggest a third dose of our vaccine within 6 to 12 months after the primary vaccine schedule may help maintain a high level of protection against the disease. (1/2)

    111 replies 366 retweetů 1 360lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit
  15. 14. 8.

    For years, 's tick-borne encephalitis vaccine has helped protect millions in endemic areas from potentially serious infection. Glad to share today’s approval to help protect people from the US traveling to or living in at-risk regions:

    9 replies 18 retweetů 127lajků
    Vrátit
  16. 13. 8.

    Vaccine doses have arrived in Trinidad & Tobago, the Bahamas, Antigua, St. Kitts & Nevis, St. Vincent & the Grenadines as part of our agreement with & CARPHA—and we will continue to ship more doses to the Caribbean nations thanks to the support of the U.S. government.

    9 replies 28 retweetů 290lajků
    Vrátit
  17. 13. 8.

    We are proud to help bring our vaccine to some of the most vulnerable among us; the emergency use authorization of a booster dose for certain immunocompromised individuals will help increase protection for this population.

    Today, FDA amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals.
    Zobrazit toto vlákno
    57 replies 52 retweetů 208lajků
    Vrátit
  18. 30. 7.

    Thank you, , for having me on to talk about everything from variants of concern to the potential need for boosters. Part one of my conversation with is available to listen to now.

    1:06
    With the Delta variant on all of our minds, meets with CEO to discuss how our vaccines measure up to the threat. Is a third shot on the horizon? Listen:
    38 replies 21 retweetů 103lajků
    Vrátit
  19. 28. 7.

    As the virus continues to evolve, and the pandemic persists in many places, we are sharing an update to our safety and efficacy results from the Pfizer-BioNTech Phase 3 study of our vaccine through up to 6 months:

    30 replies 34 retweetů 125lajků
    Vrátit
  20. 28. 7.

    I believe Q2 was a clear and powerful demonstration of the capabilities of the new . Looking forward, we intend to build upon these successes by continuing to follow the science, trust in our people and remain focused on delivering breakthroughs for the patients we serve.

    5 replies 9 retweetů 61lajků
    Zobrazit toto vlákno
    Zobrazit toto vlákno
    Vrátit

Uživatel @AlbertBourla ještě neposlal žádný Tweet.

Načítání se zjevně nějak vleče.

Možná je překročena kapacita Twitteru nebo došlo k momentálnímu zablokování. Zkuste to znovu nebo se podívejte na stavovou stránku Twitteru, kde najdete další informace.

    Také by se vám mohlo líbit

    ·